Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />
<strong>Program</strong> Description (Continued)<br />
Abstract #<br />
Monday Afternoon, March 7<br />
2:00 PM to 4:45 PM<br />
Room 207<br />
Environment and Disease<br />
Symposium Session: Human Variability in Susceptibility to<br />
Environmental Toxicants<br />
Chairperson(s): Holly Mortensen, U.S. EPA, Durham, NC, and<br />
Susan Euling, U.S. EPA, Washington, D.C.<br />
Sponsor:<br />
Molecular Biology Specialty Section<br />
Endorsed by:<br />
Regulatory and Safety Evaluation Specialty Section<br />
Risk Assessment Specialty Section<br />
Defining the differing levels <strong>of</strong> susceptibility across human populations<br />
in response to environmental chemicals can provide information to define<br />
population risk factors and in turn, allow for risk levels to be based on the<br />
most susceptible populations. Data from high-throughput/high content (HT/<br />
HC) technologies, including 'omics, have been integral in the identification<br />
and characterization <strong>of</strong> drug-target or disease loci and have the potential<br />
to be informative for characterizing the effects and dose-response assessment<br />
<strong>of</strong> chemical exposure and outcomes within genetically heterogeneous<br />
populations. Many <strong>of</strong> the same 'omics technologies have been successfully<br />
utilized to provide data that informs the mechanism <strong>of</strong> action for<br />
environmental chemicals, including the identification <strong>of</strong> perturbed toxicity<br />
pathways. In addition, large scale population genotyping studies, such as the<br />
HapMap, can help to establish levels <strong>of</strong> variability at chemical-associated,<br />
target loci across human populations, and in comparison to genome-wide<br />
patterns. Individual genotype-phenotype combinations can then be verified<br />
using in vitro methods, or extrapolation from animal models. This session<br />
includes talks on some <strong>of</strong> the latest approaches to informing population<br />
variability and the identification <strong>of</strong> susceptible populations through the use<br />
<strong>of</strong> HT/HC data, particularly from genomics technologies. We will discuss<br />
how 'omics data in combination with data from enhanced animal models,<br />
publically available datasets and related computational tools can be used<br />
to identify biomarkers, and subsequently define risk for genetically heterogeneous<br />
populations, and how this variability translates to human risk and<br />
progression <strong>of</strong> disease.<br />
#819 2:00 HUMAN VARIABILITY IN SUSCEPTIBILITY<br />
TO ENVIRONMENTAL TOXICANTS. H.<br />
Mortensen. NCCT, U.S. EPA, Research Triangle<br />
Park, NC.<br />
2:00 INTRODUCTION. Holly Mortensen<br />
#820 2:05 POPULATION-BASED DISCOVERY OF<br />
TOXICOGENOMICS BIOMARKERS FOR<br />
HEPATOTOXICITY. I. Rusyn. Environmental<br />
Sciences and Engineering, University <strong>of</strong> North<br />
Carolina at Chapel Hill, Chapel Hill, NC.<br />
#821 2:37 EXPERIMENTALLY DEFINING TOXICITY<br />
PATHWAYS USING IN VITRO HIGH-<br />
CONTENT SCREENING OF EMBRYONIC<br />
FIBROBLASTS FROM THE MOUSE<br />
DIVERSITY PANEL. R. Thomas. Genomic<br />
Biology and Bioinformatics, The Hamner Institutes<br />
for Health Sciences, Research Triangle Park, NC.<br />
#822 3:09 HERITABILITY IN DOSE RESPONSE -<br />
PUTTING THE HORSE BEFORE THE CART. <br />
A. Motsinger-Reif. Department <strong>of</strong> Statistics, North<br />
Carolina State University, Raleigh, NC. Sponsor: H.<br />
Mortensen.<br />
Abstract #<br />
#823 3:41 ASSOCIATION OF GENETIC<br />
POLYMORPHISMS, MRNA EXPRESSION<br />
OF P53 AND P21 WITH CHRONIC<br />
BENZENE POISONING IN A CHINESE<br />
OCCUPATIONAL POPULATION. N. Rothman.<br />
Division <strong>of</strong> Cancer Epidemiology and Genetics,<br />
National Cancer Institute, Bethesda, MD. Sponsor:<br />
H. Mortensen.<br />
#824 4:13 PERSONALIZED MEDICINE,<br />
INDIVIDUALIZED DRUG THERAPY:<br />
CAN THESE GOALS BE REALISTICALLY<br />
ACHIEVED? D. W. Nebert. Departments <strong>of</strong><br />
Environmental Health & Pediatrics, Division <strong>of</strong><br />
Human Genetics, University Cincinnati Medical<br />
Center, Cincinnati, OH.<br />
Monday Afternoon, March 7<br />
2:00 PM to 4:45 PM<br />
Room 204<br />
Symposium Session: Toxicological Considerations in the Gulf<br />
<strong>of</strong> Mexico Oil Spill<br />
Chairperson(s): Michael Madden, U.S. EPA, Chapel Hill, NC, and<br />
Michael Ottlinger, U.S. EPA, Cincinnati, OH.<br />
Sponsor:<br />
Occupational Public Health Specialty Section<br />
The Deepwater Horizon oil rig explosion on April 20, 2010 resulted in a<br />
release <strong>of</strong> petroleum crude oil into Gulf <strong>of</strong> Mexico waters. The release,<br />
41 miles <strong>of</strong>fshore, was about 1 mile in Department Oil dispersants were<br />
employed to change surface oil and underwater properties. Surface oil was<br />
also combusted and physical barriers deployed. Oil was estimated to have<br />
spread to an estimated 2500 square mile in the Gulf. On July 15, the well<br />
head was capped reducing oil flow to a minimum. A number <strong>of</strong> exposure<br />
uncertainties have arisen as a result <strong>of</strong> the spill related to the locations<br />
the oil has dispersed to, including volatilization to the atmosphere; and<br />
the dose <strong>of</strong> contaminant reaching wildlife, humans, and vegetation in the<br />
affected areas, and physicochemical properties <strong>of</strong> the dispersant-treated<br />
and aged oil. We will present findings related to understanding the migration<br />
<strong>of</strong> the spill components, the habitats and organisms contaminated, and<br />
the characteristics <strong>of</strong> altered crude. Routes <strong>of</strong> exposure for humans to oil<br />
components will be presented in part based on data from other studied oil<br />
spills. Knowledge <strong>of</strong> these currently unsure parameters will assist in understanding<br />
the potential biological and health effects induced by the spill. The<br />
major possible ecological effects will be described and compared to the<br />
normal Gulf ecosystem dynamics. The choice <strong>of</strong> the specific oil dispersants<br />
utilized will be discussed with an emphasis on the toxicity assays employed;<br />
toxicity endpoints still not fully examined will be identified. The types and<br />
likelihood <strong>of</strong> possible human adverse health effects, both acute and latent,<br />
will be presented in light <strong>of</strong> what will be known <strong>of</strong> the exposure routes<br />
and the conditions (e.g. heat). In order to comprehend possible effects in a<br />
comprehensive manner in order to develop estimates <strong>of</strong> various risks, the<br />
data sources available to perform such an assessment will be identified (e.g.,<br />
estimates <strong>of</strong> contaminated seafood consumption). Finally, data deficiencies<br />
needed for risk assessment will be described.<br />
#825 2:00 TOXICOLOGICAL CONSIDERATIONS IN<br />
THE GULF OF MEXICO OIL SPILL. M. C.<br />
Madden. ORD, NHEERL, HSD, Clinical Research<br />
Branch, U.S. EPA, Chapel Hill, NC.<br />
#826 2:00 THE GULF OF MEXICO ECOSYSTEM:<br />
CONSEQUENCES OF THE BP OIL SPILL. W.<br />
Benson, S. Jordan, R. Greene, V. Engle, M. Hemmer<br />
and M. Barron. Gulf Ecology Division, U.S. EPA,<br />
Gulf Breeze, FL.<br />
MONday<br />
Poster Sessions<br />
Regional Interest Session<br />
Roundtable Sessions<br />
Symposium Sessions<br />
Thematic Sessions<br />
Workshop Sessions<br />
185